Document is current
Any future updates will be listed below
-
Authors
Kamiimabeppu, Daisaku
Wakatsuki, Takeru
Takahari, Daisuke
Fukuda, Naoki
Shimozaki, Keitaro
Osumi, Hiroki
Nakayama, Izuma
Ogura, Mariko
Ooki, Akira
Shinozaki, Eiji
Chin, Keisho
Yamaguchi, Kensei
- License Information
-
More Information
Article History
Received: 28 February 2022
Accepted: 30 October 2022
First Online: 21 November 2022
Declarations
:
: Daisuke Takahari reports receiving honoraria from Taiho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co. and Eli Lilly. Kensei Yamaguchi reports receiving honoraria from Eli Lilly, receiving research funding from Eli Lilly. The other authors declare that they have no conflict of interest.
